Your new post is loading...
Your new post is loading...
|
Scooped by
Gilbert C FAURE
December 28, 2013 2:29 AM
|
Laboratory Medicine and Medical Biopathology
Laboratory Medicine is the name of a medical specialty where specialists are involved in medical diagnosis using laboratory assays to characterize molecular and cellular parameters in blood, biological fluids and tissues; It is called also clinical pathology.
|
Scooped by
Gilbert C FAURE
October 11, 4:58 AM
|
|
Scooped by
Gilbert C FAURE
August 15, 2:39 AM
|
The introduction of MDR & IVDR indicates a shift EU medical device regulation, now and in the future. We discuss the recent changes and the potential future…
|
Scooped by
Gilbert C FAURE
July 31, 4:24 AM
|
You wake with a sore throat and realise you are sick. Is this going to be a two-day or a two-week illness? Here’s how to tell the difference between these common infections.
|
Scooped by
Gilbert C FAURE
July 11, 3:29 AM
|
AbstractBackground. Medical laboratory staffing shortages have persisted, with challenges in maintaining adequate medical laboratory professionals. The car
|
Scooped by
Gilbert C FAURE
June 5, 4:26 AM
|
|
Scooped by
Gilbert C FAURE
May 4, 8:24 AM
|
If you are willing to relocate or travel, lab professional jobs exist nationwide. Here’s what you need to know about working in another state.
|
Scooped by
Gilbert C FAURE
April 29, 11:20 AM
|
|
Scooped by
Gilbert C FAURE
April 29, 10:31 AM
|
In vitro diagnostics (IVD) testing is a powerful tool for medical diagnosis, and patients‘ safety is guaranteed by a complex system of personnel qualification of the specialist in laboratory medicine, of process control, and legal restrictions in healthcare, most of them under national regulation. Direct-to-consumer laboratory testing (DTCT) is testing ordered by the consumer and performed either by the consumer at home or analysis of self-collected samples in a laboratory. However, since DTCT are not always subject to effective competent authority oversight, DTCT may pose risks to lay persons using and relying on it for healthcare decision-making. Laboratory medicine specialists should be very cautious when new DTCTs are introduced. As qualified professionals, they should feel obliged to warn and educate patients and the public about the risks of inappropriate and harmful DTCT.
|
Scooped by
Gilbert C FAURE
April 29, 10:26 AM
|
Direct-to-consumer genetic testing is done with tests bought online or in stores. It is sometimes called at-home genetic testing or home DNA testing. Learn more about these tests.
|
Scooped by
Gilbert C FAURE
April 26, 10:03 AM
|
According to Vision Research Reports, the Europe in vitro diagnostics market size is calculated at USD 26.97 billion in 2024 and is expected to surpass around USD 28.77 billion by 2033, poised to grow at a CAGR of 0.72% from 2024 to 2033.
|
Scooped by
Gilbert C FAURE
April 24, 4:35 AM
|
|
Scooped by
Gilbert C FAURE
April 22, 5:15 AM
|
As we wrap up the closing day of the POCT Advances Conference, I'm filled with a profound sense of gratitude and inspiration. This event has been an incredible…
|
|
Scooped by
Gilbert C FAURE
November 12, 4:36 AM
|
The application of chatbots and Natural Language Processing (NLP) in cytology and cytopathology is an emerging field, which is currently characterized by a limited but growing body of research. Here, a narrative review has been proposed utilizing a standardized checklist and quality control...
|
Scooped by
Gilbert C FAURE
September 13, 3:48 AM
|
Abstract. The critical nature of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the p
|
Scooped by
Gilbert C FAURE
August 3, 5:19 AM
|
La HAS a été saisie par le ministère chargé de la Santé pour évaluer des actes onéreux inscrits sur le référentiel des actes innovants hors nomenclature (RIHN), en vue de leur prise en charge de droit commun. En contribuant activement à relancer le caractère dynamique de cet outil de soutien à l’innovation, la HAS confirme son engagement à favoriser un accès précoce et équitable des patients à l’innovation en santé.
|
Scooped by
Gilbert C FAURE
July 20, 8:48 AM
|
|
Scooped by
Gilbert C FAURE
June 6, 1:20 PM
|
U.S. Clinical Laboratory Tests Market Size, Share, Trends and industry analysis now available from IndustryARC. Report reveals U.S. Clinical Laboratory Tests Market in the industry by Type, Products and Application.
|
Scooped by
Gilbert C FAURE
May 28, 1:30 PM
|
Probably the best Public Health tool available in the US to track near real-time the circulation of multiple infectious diseases by monitoring wastewater…
|
Scooped by
Gilbert C FAURE
April 30, 3:55 AM
|
ARUP maintains that the FDA’s rule will limit access to testing, stifle innovation, and increase healthcare costs.
|
Scooped by
Gilbert C FAURE
April 29, 10:35 AM
|
Direct-to-consumer (DTC) tests can be defined as any in-vitro diagnostic (IVD) test or, more broadly, any medical test using an IVD or medical device, that is marketed directly to consumers without involvement of a health care provider (HCP). Examples are pregnancy tests, alcohol breath tests, blood pressure measurements (medical device), coagulation tests (INR), self-monitoring of blood glucose, continuous glucose monitoring (medical device), HIV tests, HPV tests, SARS-CoV-2 antigen tests, or genetic tests. DTC tests fulfil various customer needs such as making rapid decisions (e.g. glucose monitoring for insulin dosing, SARS-CoV-2 antigen test, hormone test identifying fertile days, alcohol test), monitoring chronic conditions between consultations (e.g. diabetes, lipidaemia, hypertension), saving time and reducing consultations (e.g. INR, SARS-CoV-2 antigen test, blood pressure monitoring), screening for disease when no symptoms are present (e.g. occult blood, cholesterol, triglycerides, SARS-CoV2 antigen test), or maintaining privacy (e.g. pregnancy test, HIV test, HPV test, certain genetic tests). Further, DTC tests can reduce cost and expand access to care in countries with limited resources and can support healthcare systems in extraordinary circumstances such as a pandemic. Valid concerns about DTC testing need to be described, addressed and resolved with the help of authorities and regulators in collaboration with HCP and should not detract from the advantages DTC tests can provide. HCP should play a more prominent role in educating the public through mass media and social media on the proper use of DTC tests and help to pinpoint problem areas.
|
Scooped by
Gilbert C FAURE
April 29, 10:29 AM
|
|
Scooped by
Gilbert C FAURE
April 28, 12:50 PM
|
<em>CA: A Cancer Journal for Clinicians</em> is ACS' flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
|
Scooped by
Gilbert C FAURE
April 24, 4:48 AM
|
A simple and convenient method to collect drug use data from the surface of a smartphone is revealed for the first time in a new study published in De Gruyter's Clinical Chemistry and Laboratory Medicine.
|
Scooped by
Gilbert C FAURE
April 22, 12:52 PM
|
The first test to diagnose Long COVID is due to launch in the UK and EU as a result of a collaboration between two health tech companies, PeploBio and IncellDX.
|
Scooped by
Gilbert C FAURE
April 22, 4:33 AM
|
|
The same applies for an Immunology lab.
The post is quite interesting, pointing out crucial aspects of errors at the lab.
External Proficiency Testing is just one of the tools for avoiding some error sources
"So maybe the next time your boss comes to you and says “Congratulations, so far this year we have had no errors, and no complaints from laboratory users”, maybe the response should be “So what are we doing wrong?….”